HS Code 30021230.0 — Antisera and other blood fractions
Chapter 30 (Pharmaceutical Products) · Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) · Last updated: April 2026 · Source: Indian Customs (DGFT) Records
HS Code 30021230.0 (Antisera and other blood fractions) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $61 across 1 shipments, this code covers 1 distinct pharmaceutical products exported by 4 Indian manufacturers to 10 countries. The leading product under this classification is Rituximab at $61, followed by .
The top importing markets include Russia, Sri Lanka, Colombia. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $61. Leading exporters include DR.REDDY'S LABORATORIES LTD and RELIANCE LIFE SCIENCES PRIVATE LIMITED. Data sourced from Indian Customs (DGFT) shipping bill records.
Products Exported Under HS Code 30021230.0
1 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Rituximab | $61 | 1 | $20.42 | 1 |
Import Destinations — HS Code 30021230.0
10 countries import products classified under HS Code 30021230.0 from India
Indian pharmaceutical exports under HS Code 30021230.0 reach 10 countries worldwide. The largest importer is Russia ($9.0M), followed by Sri Lanka ($2.2M), Colombia ($1.2M), Venezuela ($1.1M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.